Clinical Trials Logo

Uterine Cervical Neoplasms clinical trials

View clinical trials related to Uterine Cervical Neoplasms.

Filter by:

NCT ID: NCT05779111 Completed - Radiotherapy Clinical Trials

A Retrospective Analysis: Whether Five Factors Affect PFS in Patients With Locally Advanced Cervical Cancer

Start date: February 10, 2022
Phase:
Study type: Observational

In previous studies, the investigators found that five factors were effective in predicting the probability of locally advanced cervical cancer with para-aortic lymph node metastasis.A retrospective study was conducted to explore the influence of 5 factors on PFS in patients with locally advanced cervical cancer receiving radiotherapy and chemotherapy.

NCT ID: NCT05756192 Completed - Clinical trials for Human Papilloma Virus

Educational Video's Impact on Knowledge Regarding Cervical Cancer Screening

Start date: November 1, 2022
Phase: N/A
Study type: Interventional

The researchers will be conducting a prospective randomized trial where the researchers will be introducing an educational video to see whether there is an increase in knowledge scores surrounding cervical cancer, cervical cancer screening, and prevention with HPV vaccinations.

NCT ID: NCT05746156 Completed - Clinical trials for Locally Advanced Cervical Cancer

Lymphatic Mapping for Image Guided Radiotherapy in Patients With LACC - a Feasibility Study

LaMA
Start date: July 20, 2020
Phase: N/A
Study type: Interventional

Lymphatic mapping is a procedure in which all lymph nodes with drainage from the primary tumor, i.e. all nodes with potential (micro)metastases, can be imaged. These nodes are not necessarily suspicious on other imaging techniques. The goal of this feasibility study is to 1. investigate the feasibility of the lymphatic mapping procedure in locally advanced cervical cancer 2. study the agreement of the lymphatic map with the radiotherapy treatment plan including previous imaging (MRI / CT / FDG-PET/CT)

NCT ID: NCT05736315 Completed - Clinical trials for Cervical Cancer, Stage IIB

Use of a Fermented Dairy Beverage in Cervical Cancer Patients Undergoing Concurrent Chemoradiation Therapy

Start date: April 25, 2005
Phase: N/A
Study type: Interventional

Many cancer survivors have increased risk of intestinal damage, affecting the quality of life of patients. The role of intestinal microbiota on the development of gastrointestinal toxicity and radiation enteritis has been described in cervical cancer patients that received pelvic RT. In this project we investigated the effect that a fermented dairy beverage (Yakult) may have in the modulation of inflammation and consequently of gastrointestinal toxicity in locally advanced cervical cancer (LACC) patients treated with concomitant chemo-radiotherapy (CRT).

NCT ID: NCT05717751 Completed - Clinical trials for Locally Advanced Cervical Cancer

Predictors of Para-aortic Lymph Node Metastasis of Cervical Cancer

Start date: April 13, 2022
Phase:
Study type: Observational

The goal of this observational study is to identify predictive factors and to develop a risk model predicting para-aortic lymph node metastasis in patients with locally advanced cervical cancer based on the analysis of surgical staging results. The main questions it aims to answer are: - What are the risk factors to predict para-aortic lymph node metastasis in patients with locally advanced cervical cancer? - What is the indication for prophylactic extended-field radiation therapy in patients with locally advanced cervical cancer Individual data of patients with locally advanced cervical cancer treated with surgical staging at our institution from 2020 to 2022 were pooled analysed.Multivariate Logistic regression analysis was used to identify the predictive factors and to develop the prediction model.

NCT ID: NCT05622760 Completed - Anxiety Clinical Trials

Impact of the Different Information Channels in Reducing Anxiety in Participants of Cervical Cancer Screening

DICRA
Start date: May 17, 2022
Phase: N/A
Study type: Interventional

When participating in population-based screening for cervical cancer, women experience great anxiety during the weeks of waiting since they learn that they have an altered screening result until the colposcopy is performed. In this study we want to verify how anxiety decreases when the information is improved and an audiovisual support is added when giving it.

NCT ID: NCT05564286 Completed - Cervical Cancer Clinical Trials

Triple Antiemetic Regimen for Chemoradiotherapy in Cervical Cancer or Nasopharyngeal Cancer

Start date: July 1, 2021
Phase: Phase 3
Study type: Interventional

The study is to evaluate the antiemetic effect of adding fosaprepitant to biplet regimen of tropisetron and dexamethasone for patients with cervical cancer or nasopharyngeal cancer treated with radiotherapy and concomitant weekly cisplatin chemotherapy in a south Chinese cohort.

NCT ID: NCT05537012 Completed - Cervical Cancer Clinical Trials

Incidence of Unresectable Cases of Cervical Cancer

Start date: March 1, 2019
Phase:
Study type: Observational

Objective : to calculate the incidence of unresectable cases of cervical cancer in gyne-oncology unit of Alexandria university hospital and to indentify its relation to pathological types, grading and lymph vascular space invasion. Patients and methods: 70 cases of cervical cancer diagnosed by biopsy taking and histopathological examination will be included in the study, clinicoradiological staging was done to all cases to calculate the incidence of unresectable cases and to indentify its relation to pathological types, grading and lymph vascular space invasion

NCT ID: NCT05529303 Completed - Ovarian Cancer Clinical Trials

Prolonged Grief and Perception of Femininity in Gynecological Cancer Patients

Start date: February 26, 2023
Phase: N/A
Study type: Interventional

The aim of this study is to determine the effect of the 'Feminine Identity Improvement Program', based on cognitive behavioral and expressive techniques applied to gynecological cancer patients, on prolonged grief reactions and the perception of femininity. The study will be conducted in a randomized controlled and qualitative type with gynecological cancer patients who completed their surgical treatment at least three months ago in the last year at Afyonkarahisar Health Sciences University Hospital.

NCT ID: NCT05511740 Completed - Cervical Cancer Clinical Trials

Circadian as A Prognostic Factor For Radiation Response in Cervical Cancer

Start date: January 2010
Phase: N/A
Study type: Interventional

The study was a Randomized Clinical Trial (RCT) or clinical trial comparing the results of radiation treatment of 2 treatment groups, i.e. subject groups irradiated in the morning and in the afternoon, to check melatonin levels in cervical cancer patients. Since it is known that the function of melatonin is as an antiproliferation substance or hormone, induces apoptosis, inhibits invasion and metastasis.